Comparison

K00135 European Partner

Item no. HY-123141
Manufacturer MedChem Express
CASRN 869650-21-5
Amount 1 ea
Quantity options 1 ea 10 mM / 1 mL 10 mg 1 mg 5 mg
Category
Type Standard
Specific against other
Purity 98.03
Citations [1]Pogacic V, et al. Structural analysis identifies imidazo [1, 2-b] pyridazines as PIM kinase inhibitors with in vitro antileukemic activity[J]. Cancer research, 2007, 67(14): 6916-6924.
Smiles CC(C1=CC=CC(C2=CN=C3C=CC(NCC4CC4)=NN32)=C1)=O
ECLASS 10.1 42021590
ECLASS 11.0 42021590
UNSPSC 12352202
Shipping Condition Cool pack
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Cancer-Kinase/protease
Manufacturer - Category
Reference compound / Active compounds
Manufacturer - Targets
Pim
Shipping Temperature
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Molecular Weight
306.36
Product Description
K00135 is a potent and selective inhibitor of PIM kinases. K00135 inhibits survival and clonogenic growth of acute leukemia cells. K00135 inhibits the phosphorylation of PIM downstream targets[1].
Manufacturer - Research Area
Cancer
Solubility
DMSO : 11.67 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturer - Pathway
JAK/STAT Signaling
Clinical information
No Development Reported
UNSPSC Code
12352005

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?